ABSTRACT
Psoriatic arthritis (PsA) is a chronic inflammatory disorder which develops in association with psoriasis in which rheumatoid factor (RF) is usually negative and there are no rheumatoid nodules. It is classified within the group of seronegative spondyloarthropathies.
1,2 Since PsA does not have a widely accepted classification and diagnostic criteria, it is hard to estimate its prevalence. 3 Classification of Psoriatic Arthritis (CASPAR) criteria was published in 2006. 1 To our knowledge, there are only a few prevalence or incidence studies which used CASPAR criteria in relevant English literature. [4] [5] [6] In this study, we aimed to investigate PsA prevalence in patients with psoriasis, and clinical and laboratory characteristics of the patients. All of the participants were informed about treatment procedure and their signed informed consents were obtained. Patients were screened for PsA using CASPAR criteria. 7 The patients were also evaluated by a physiatrist of our clinic. Age, gender, psoriasis duration and arthritis duration of the patients as well as nail involvement and presence of dactylitis were noted. Peripheral joints and spine of the patients were examined in detail. Examination of 13 sensitive points was performed to diagnose enthesopathy according to Maastricht Ankylosing Spondylitis Enthesis Score. 8 PsA patients were grouped into five subtypes according to Moll and Wright criteria. 2 The Psoriasis Area and Severity Index (PASI) scores of the patients were calculated by the same dermatologist. 9, 10 The patients were grouped according to their PASI scores as follows: <3: mild; 3-15: moderate; and >15: severe psoriasis. Blood samples were obtained from all patients to measure erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and RF using turbidimetric method. In those patients with inflammatory back pain, radiological assessments including X-ray or magnetic resonance imaging of sacroiliac joints were performed.
PATIENTS AND METHODS

Statistical analysis
The statistical analysis of data was performed using SPSS for Windows version 11.5 package program (SPSS Inc., Chicago, IL, USA). The normality of continuous variables was analyzed using Shapiro Wilk test. The descriptive statistics were presented as mean ± standard deviation or median [minimum (min.)-maximum (max.)] for continuous variables, and as the number of the cases and (%) for categorical variables. The significance of difference between the means of the groups was investigated using Student's t test while the significance of the difference between the medians was investigated using Mann-Whitney U test. Categorical variables were analyzed using Pearson's Chi-square test. P<0.05 was considered as statistically significant.
RESULTS
Thirty-two patients (25.4%) had PsA according to CASPAR classification criteria. 1 The demographic characteristics of the patients are summarized in Table 1 . The duration of psoriasis was longer in arthritis (+) group (p<0.05).
The onset time of psoriasis and PsA were investigated. Arthritis and psoriasis which started within one year was regarded as simultaneous onset. Arthritis started before psoriatic lesions in three (9.4%) of 32 patients, simultaneously with psoriasis in one patient (3.1%), and after psoriatic skin lesions in 28 patients (87.5%).
According to Moll and Wright criteria, some patients with PsA were included in more than one subgroup (Table 2 ). Most common types were asymmetrical oligoarticular type (53.1%) and spondylitis type (43.8%). There was no difference with respect to gender when 14 patients (8 males, 6 females) with spondylitis were compared to 18 patients (10 males, 8 females) without spondylitis (p>0.05). Sacroiliitis was detected in 12 patients (37.5%). Sacroiliitis was detected with anteroposterior pelvic X-ray in six patients (50%) and magnetic resonance imaging in the other six patients (50%). Dactylitis was detected in seven patients (21.9%) and enthesopathy in 20 patients There were 65 patients (51.6%) with nail involvement. While 42 (44.7%) of these patients were in arthritis (-) group, 23 (71.9%) were in arthritis (+) group (p<0.01) ( Table 3) . Laboratory results revealed that ESR and CRP levels were higher in arthritis (+) group than in arthritis (-) group (both p values <0.01).
The mean PASI score was higher in arthritis (+) group than in arthritis (-) group (p<0.05). No statistically significant difference was detected when the groups were compared according to the severity of the PASI scores (Table 3) .
DISCUSSION
In several studies the prevalence of PsA in patients with psoriasis was 42% with Moll and Wright criteria, 11 7.7% 12 and 9.1% 13 with European Spondylarthropathy Study Group classification criteria, and 13.8% with CASPAR. 4 Maldonado
Ficco et al. 6 reported the prevalence of PsA according to CASPAR criteria, Assessment of SpondyloArthritis International Society peripheral and axial spondyloarthropahty criteria, and New York criteria for ankylosing spondylitis. The first 100 patients consecutively attending a psoriasis dermatology clinic were assessed. Seventeen patients had peripheral arthritis as follows: nine mono/oligoarticular and eight polyarthritis. Seventeen percent of patients fulfilled CASPAR and Assessment of SpondyloArthritis International Society peripheral criteria, 6% New York, and 5% Assessment of Spondylo Arthritis International Society axial criteria. Kumar et al. 5 reported the prevalence of PsA according to CASPAR criteria as 8.7% in 1,149 psoriasis patients. Various prevalence in the literature may be related to the number of the patients included in the studies and the differences of the classification criteria employed in the diagnosis of PsA. For instance, a study using Moll and Wright criteria 11 showed higher prevalence. This may be associated with regional difference or classification criteria. In addition, the differences in the patient populations included in the studies may play role on the outcomes. For example, studies including patients with severe symptoms reported high prevalence.
There are conflicting results about the relationship of psoriasis duration and development of PsA. Wilson et al. 14 reported that calendar year was not related to risk of PsA development. On the other hand, Gladman et al. 15 reported that development of deforming arthritis such as arthritis multilans was related with early onset of psoriasis. In our study, we found that duration of psoriasis was significantly longer in arthritis (+) group and the probability of PsA development was higher in patients with long lasting psoriasis.
Although some studies indicate that males and females were affected equally by PsA, 4,13 some series report a female predominance 12 while others report a male predominance. 15 In our series, the frequency of arthritis was higher in males, although not statistically significant.
Our classification of PsA according to Moll and Wright criteria revealed that the oligoarticular type was more common 2, 16, 17 whereas other studies demonstrated that polyarticular type was the most common, 15 or found similar prevalence for oligoarthritis and polyarthritis. 18 We detected spondylitis in 43.8% and isolated spondylitis in 21.9% of the patients. These ratios were higher than the ones previously reported in the literature. The spondylitis of PsA is uncommon as a predominant feature, and accounts for only approximately 5% of the cases. 19 However, spondylitis was reported as 20-40% in patients with PsA after careful clinical and radiological assessments. 19 Dactylitis is an important finding of PsA and is reported in between 12-48% of the patients. [20] [21] [22] In our study, we noted dactylitis in 22% of the patients.
Enthesitis is another important finding of PsA. Some investigators have emphasized that enthesitis is the primary finding of PsA. 4, 13, 23 Plantar fascia and the insertion point of Achilles tendon to the heel are the most frequently involved sites. 24 Ibrahim et al. 4 detected enthesitis in 83.3% of their patients while another study from Iran 13 reported this value as 20.7%. We found enthesitis in 62.5% of patients with PsA, and enthesopathy was frequently seen in Achilles tendon.
Psoriasis Area and Severity Index is a widely accepted psoriasis evaluation index used as an outcome measure. 10 Although some studies indicated more severe skin lesions in patients with PsA, 13 other studies reported lesions and joint involvement. 23 We detected significantly higher mean PASI scores in patients with PsA.
Nail involvement is more common in patients with PsA and is an important finding that supports diagnosis of PsA. 25 While nail involvement is observed in 40-49% of psoriasis patients, it is seen in 57-97% of patients with PsA.
3,11,13,22 Nail involvement is common in patients with distal interphalangeal joint involvement. 2, 9, 25 In our study, we detected nail involvement to be 44.7% in arthritis (-) group and 71.9% in arthritis (+) group. All patients with distal interphalangeal joint involvement had nail involvement as well.
High ESR and CRP are among the most characteristic laboratory abnormalities in patients with PsA. 21, 26, 27 In our study, we also detected significantly higher ESR and CRP levels in the group with PsA. Although patients with PsA are typically seronegative for RF, in a study RF was positive in 5-9% of the patients. 26 We did not find RF positivity in any of our PsA patients.
In conclusion, the prevalence of PsA was determined as 25.4% in our study. According to Moll and Wright criteria, the most common type was asymmetrical oligoarticular type. Higher isolated spondylitis rate (22%) in our patients with PsA indicates that PsA must be kept in mind in the differential diagnosis of spondylitis, particularly ankylosing spondylitis. In addition, longer duration of psoriasis, and more common nail involvement and severe skin lesions in psoriasis may guide the clinician for the probability of PsA development in these patients.
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